Fennec Pharmaceuticals Inc (FENC) — Cash Flow-to-Debt Ratio
Fennec Pharmaceuticals Inc (FENC) has a Cash Flow-to-Debt Ratio of -0.17x as of December 2025, meaning its operating cash flow of $-5.96 Million could theoretically repay 0% of its total liabilities ($35.02 Million) in one year. See Fennec Pharmaceuticals Inc (FENC) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Fennec Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1999–2025)
Historical debt coverage capacity for Fennec Pharmaceuticals Inc across 26 annual periods. Also explore FENC net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Fennec Pharmaceuticals Inc (1999–2025)
Year-by-year debt coverage analysis for Fennec Pharmaceuticals Inc. For market capitalisation and broader financial context, see how much is Fennec Pharmaceuticals Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.36x | $-12.47 Million | $35.02 Million | ▼ -167.1% |
| 2024 | 0.53x | $26.98 Million | $50.82 Million | ▲ +219.2% |
| 2023 | -0.45x | $-17.14 Million | $38.49 Million | ▲ +27.2% |
| 2022 | -0.61x | $-18.06 Million | $29.51 Million | ▲ +71.4% |
| 2021 | -2.14x | $-14.22 Million | $6.64 Million | ▲ +67.8% |
| 2020 | -6.64x | $-15.60 Million | $2.35 Million | ▼ -66.6% |
| 2019 | -3.99x | $-9.06 Million | $2.27 Million | ▲ +16.6% |
| 2018 | -4.78x | $-7.83 Million | $1.64 Million | ▼ -115.9% |
| 2017 | -2.21x | $-3.64 Million | $1.64 Million | ▲ +58.1% |
| 2016 | -5.28x | $-2.12 Million | $402.00K | ▼ -33.7% |
| 2015 | -3.95x | $-1.86 Million | $471.00K | ▼ -309.3% |
| 2014 | -0.97x | $-1.70 Million | $1.76 Million | ▼ -40.2% |
| 2013 | -0.69x | $-2.21 Million | $3.21 Million | ▼ -68.5% |
| 2012 | -0.41x | $-2.99 Million | $7.32 Million | ▲ +30.7% |
| 2011 | -0.59x | $-3.23 Million | $5.47 Million | ▼ -233.9% |
| 2010 | -0.18x | $-1.93 Million | $10.92 Million | ▲ +98.4% |
| 2009 | -10.98x | $-4.69 Million | $427.00K | ▼ -205.5% |
| 2008 | -3.59x | $-10.81 Million | $3.01 Million | ▲ +17.3% |
| 2007 | -4.35x | $-13.30 Million | $3.06 Million | ▼ -190.2% |
| 2006 | -1.50x | $-13.47 Million | $9.00 Million | ▼ -2.4% |
| 2005 | -1.46x | $-12.26 Million | $8.39 Million | ▼ -113.1% |
| 2003 | -0.69x | $-5.99 Million | $8.73 Million | ▼ -30.7% |
| 2002 | -0.52x | $-5.43 Million | $10.35 Million | ▲ +88.0% |
| 2001 | -4.39x | $-3.23 Million | $736.04K | ▼ -3.7% |
| 2000 | -4.23x | $-2.69 Million | $635.41K | ▼ -106.2% |
| 1999 | -2.05x | $-1.22 Million | $596.46K | — |